Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2015-02-27 Annual Report
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
2014 annual report - ENG.pdf
Annual Report Classification · 100% confidence The document is a comprehensive annual report for UCB, containing a letter to stakeholders, management reports, consolidated financial statements, notes to financial statements, and auditor reports. It covers the company's performance, strategy, and financial results for the 2014 fiscal year. It is clearly the full annual report rather than an announcement or a summary. FY 2014
2015-02-27 English
2014 annual report - FR.pdf
Annual Report Classification · 100% confidence The document is a comprehensive annual report for UCB, containing a letter to stakeholders, management reports, financial statements, notes to financial statements, and auditor reports. It covers the company's performance, strategy, and financial results for the 2014 fiscal year. It is clearly an annual report rather than a short announcement or a specific regulatory filing. FY 2014
2015-02-27 French
2014 annual report - NL.pdf
Annual Report Classification · 100% confidence The document is a comprehensive annual report for UCB, containing a letter to stakeholders, management reports, consolidated financial statements, and performance indicators for the fiscal year 2014. It is clearly a full annual report rather than an announcement or a summary, as it includes detailed financial data and governance disclosures. FY 2014
2015-02-27 Dutch
UCB FY 2014_ en_final.pdf
Report Publication Announcement Classification · 95% confidence The document is a press release titled 'UCB Full Year Report 2014' which provides a summary of financial highlights, operational performance, and R&D updates. While it contains significant financial data, it explicitly states at the end that 'A full financial report on the consolidated results is available on the UCB website', indicating this document is an announcement of the annual results rather than the full 10-K/Annual Report itself. According to the 'MENU VS MEAL' rule, this is classified as a Report Publication Announcement (RPA). FY 2014
2015-02-27 English
UCB_FY2014_ fr_final.pdf
Earnings Release Classification · 97% confidence The document is titled "UCB - Résultats financiers 2014" (Financial Results 2014) and contains detailed financial performance metrics for the full year 2014, including revenue, EBITDA, net income, and forward-looking guidance for 2015. It explicitly mentions key financial figures, R&D pipeline updates, and proposes a dividend. The text is comprehensive, covering the entire fiscal year, which strongly suggests an Annual Report or a detailed Earnings Release/Interim Report. Since it covers the full year and provides extensive detail, it aligns best with the scope of a comprehensive annual financial disclosure. However, the text begins with "Information réglementée" (Regulated Information) and provides a link to the full report: "Le rapport financier complet sur base des états consolidés est disponible sur le site d'UCB". This structure—a detailed summary announcement with a reference to the full report—is characteristic of an Earnings Release (ER) or, given the comprehensive nature covering the full year, sometimes overlaps with the content of a 10-K, but the format here is a press release summarizing results. Given the detailed financial tables and the focus on full-year results, it is more substantial than a typical quarterly ER. If this were a 10-K, it would likely contain more explicit SEC/regulatory headers (which are absent, though it is a European company, suggesting local filing rules). Since it details the full year's performance and outlook, it is a strong candidate for an Annual Report (10-K equivalent) or a very detailed Earnings Release. Given the structure and the explicit mention of the full consolidated financial report being available elsewhere, this document functions as the primary announcement of the annual results, fitting the definition of an Earnings Release (ER) which often includes full-year summaries when released, or potentially an Interim Report (IR) if the company uses this format for its annual summary. However, the depth of the financial tables and the full-year focus push it beyond a standard quarterly ER. Since it is a full-year summary, and not explicitly labeled as a 10-K, the closest fit among the provided options for a comprehensive annual financial announcement that is not the full statutory filing is often the Earnings Release (ER) or, if it were half-yearly, an IR. Given the context of a full-year review, and the fact that it is a press release format, ER is plausible, but IR is defined as 'comprehensive financial report for a period shorter than a year'. Since this covers the full year, and is not explicitly a 10-K, I will classify it as the most comprehensive non-statutory report available, which often defaults to ER if the full 10-K is not present, or IR if the company treats its annual report like a comprehensive interim report. Given the extensive detail and full-year scope, it is highly likely this is the primary document announcing the annual results, which is best categorized as an Earnings Release (ER) in this context, or potentially an Interim Report (IR) if the company's annual reporting cycle is structured this way, though IR usually implies 'interim' (less than a year). Since it is a full-year result announcement, and the document is substantial (over 20k chars), it is not an RPA. I will select ER as the best fit for a detailed annual results press release. FY 2014
2015-02-27 French
UCB_FY2014_ nl_final.pdf
Earnings Release Classification · 95% confidence The document is an earnings release for UCB for the full year 2014. It contains key financial highlights, revenue breakdowns, EBITDA, net profit, and forward-looking guidance for 2015. While it mentions that the full annual report is available on the website, the document itself provides a comprehensive summary of the financial results and operational performance, which is characteristic of an Earnings Release (ER). FY 2014
2015-02-27 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.